Yuanhe Fund

Yuanhe applies a sector-specialist model grounded in Yantai’s industrial base, using deep supply-chain mapping within its six target verticals to identify companies that can scale through integration with local manufacturers. Public announcements suggest the firm also co-invests alongside state-backed strategic investors — in May 2026 it reported that Sinopec Capital invested in portfolio-adjacent company Yantai Wanhua Electronic Materials, indicating connectivity to state-directed capital (per the firm, May 2026). This sourcing pattern produces deal flow that is concentrated in the Bohai economic rim and adjacent advanced-manufacturing clusters.

Yuanhe engages in both direct equity investments and limited-partner commitments. The firm disclosed that it accessed Saiying Electronics, which listed on the Beijing Stock Exchange in April 2026, through a fund in which it was a participant — indicating a fund-of-funds or parallel-vehicle sleeve alongside its direct book (per the firm, April 2026). This dual approach allows the firm to back managers targeting its verticals while maintaining the ability to lead or co-lead direct rounds.

The firm operates across early-stage, seed, start-up, and growth stages, spanning venture and expansion capital. Its portfolio disclosures show the full lifecycle: from early-stage biomedical companies like Shali Biotechnology to later-stage industrial companies like Shanghai Junyi Industrial Automation and pre-IPO power-semiconductor manufacturer Saiying Electronics. The stage flexibility is consistent with a model that prioritizes sector alignment over stage rigidity.

Yuanhe does not publish a formal exclusion list, but its stated six focuses — new energy, new materials, biomedicine, intelligent manufacturing, military-aerospace, and information technology — define a hard-tech mandate. Consumer internet, platform-marketplace businesses, and pure software-as-a-service models are absent from its public portfolio and communications, making them effectively outside the investment perimeter. The firm's industrial-policy posture makes regulated or consumer-facing sectors unlikely targets.

Yuanhe does not publicly disclose the names or backgrounds of its management team or investment committee members. The firm's website describes its team and culture only in general terms, and no LinkedIn presence provides supplementary detail. For an institutional allocator, governance and key-person risk remain unobservable from primary public sources (Altss research).

The most concrete exit signal is the April 2026 Beijing Stock Exchange listing of Saiying Electronics, a portfolio company accessed through one of the firm's fund commitments (per the firm, April 2026). Beyond this single disclosed public-market exit, track record data, distribution timelines, and net multiples are not publicly available. The firm’s communications focus on portfolio-company milestones rather than fund-level performance metrics.

No philanthropic foundation, donor-advised fund, or separately governed non-investment entity is disclosed on the firm’s website or in public records. The firm’s public-facing activity outside of investing is limited to regulatory-outreach campaigns — such as the investor-protection education initiative it promoted in May 2026 — which align with regulatory compliance rather than a distinct philanthropic mission.